BLOOD PRESSURE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2018-06-13 elisha1986922

我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表::
研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表:
审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表.

匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表.

277 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2021-12-28 衣谷

实验数据被抢先发表了怎么办？

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2021-12-27 小动量

讨论怎么写？

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2019-03-29 才开始

请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表::
接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表:
投过去1周六被拒了，说文章缺乏新颖性

182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性

124 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2018-08-20 12036578m75(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投过去1周六被拒了，说文章缺乏新颖性

179 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2018-06-13 elisha1986922

为什么呢?王帅兵 2018-01-31 发表::
SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表:
修稿修了3次.最后被拒.郁闷

王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷

173 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2018-06-13 elisha1986922

不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表::
研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表:
审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表.

匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表.

246 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2018-01-31 asdfgrtuj

修稿修了3次，最后被拒，郁闷

275 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2017-12-08 ms7926137929713482

审稿速度:1.0 | 投稿命中率:75.0
经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。

200 0

[GetPortalCommentsPageByObjectIdResponse(id=557894, encodeId=ba1855e89474, content=我能问一下他的reference 的格式是哪款?它对文章格式有什么要求?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088083, encodeId=dfbd10880830b, content=实验数据被抢先发表了怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088084, encodeId=b1111088084d1, content=讨论怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568779, encodeId=3e1f568e7978, content=请问这个杂志1审周期正常是一个月吗？182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性182W79f0175(暂无昵称) 2018-08-20 00:00:00 发表: 投过去1周六被拒了，说文章缺乏新颖性, beContent=182W79f0175(暂无昵称) 2018-08-20 发表:: 接收率：约25% 审稿时间：约1个月投过去1周六被拒了，说文章缺乏新颖性, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Fri Mar 29 00:00:00 CST 2019, time=2019-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=560267, encodeId=b3d756026e31, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去1周六被拒了，说文章缺乏新颖性, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/ibicd9KhTUffKzxxVTOst9RAXYUriapaLFwP31AP0iaicE4aDRmwMpL3cXQoDVemwfk4FHMFhFKViahlQOGnwnpVj1HA/132, createdBy=d2252162806, createdName=12036578m75(暂无昵称), createdTime=Mon Aug 20 00:00:00 CST 2018, time=2018-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557893, encodeId=6deb55e8930a, content=为什么呢?王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷asdfgrtuj 2018-01-31 08:46:00 发表: 修稿修了3次.最后被拒.郁闷, beContent=王帅兵 2018-01-31 发表:: SCI(2016):2.163 SCI(2015):2.01 SCI(2014):1.808 修稿修了3次.最后被拒.郁闷, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557895, encodeId=4e2b55e89531, content=不好意思.补充问一下.我看到blood pressure里文章表格有些蓝色是我们自己编辑吗?匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表. 2017-12-08 08:22:00 发表: 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., beContent=匿名 2017-12-08 发表:: 研究方向:临床;高血压; 接收率:约75% 审稿时间:约1个月 SCI(2016):2.163 审稿速度快.编辑态度友好.提的问题也是帮助提高文章质量.投的一篇临床文章.8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表., objectType=tool_impact_factor, channel=null, level=null, likeNumber=246, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2821418776, createdName=elisha1986922, createdTime=Wed Jun 13 00:00:00 CST 2018, time=2018-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552198, encodeId=edff55219883, content=修稿修了3次，最后被拒，郁闷, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ea1944686, createdName=asdfgrtuj, createdTime=Wed Jan 31 08:46:00 CST 2018, time=2018-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549827, encodeId=d78554982eb5, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：审稿速度快，编辑态度友好，提的问题也是帮助提高文章质量，投的一篇临床文章，8.23 submitted 9.1 major revision 11.5修回 11.16 accept 目前已online发表。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9df81829338, createdName=ms7926137929713482, createdTime=Fri Dec 08 08:22:00 CST 2017, time=2017-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547162, encodeId=8a1e54e162e7, content=有人知道这个杂志审稿周期大概多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Thu Sep 14 16:22:00 CST 2017, time=2017-09-14, status=1, ipAttribution=)]

2017-09-14 ghyang.cardiolab

有人知道这个杂志审稿周期大概多久吗

206 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务